about
Introduction to radiobiology of targeted radionuclide therapyImpact of α-targeted radiation therapy on gene expression in a pre-clinical model for disseminated peritoneal disease when combined with paclitaxel.Radioimmunotherapy with α-particle-emitting radionuclides.Rescue effects: irradiated cells helped by unirradiated bystander cellsThe safety and treatment response of combination therapy of radioimmunotherapy and radiofrequency ablation for solid tumor: a study in vivo.Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction.Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.Improving external beam radiotherapy by combination with internal irradiationAddressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma.Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapyAntibody drug conjugates.Radioimmunotherapy for CD133(+) colonic cancer stem cells inhibits tumor development in nude mice.Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer models.Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers.Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types.Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients.In vivo demonstration of an active tumor pretargeting approach with peptide nucleic acid bioconjugates as complementary system.
P2860
Q26852029-2383DDA6-86F8-4E18-AF7F-6DEAB93369BEQ34277296-3242BDD9-DBAB-4901-8E3C-2C3024AB6281Q34419562-847CB7EC-F1C4-4A3B-A960-D2207DB893D7Q35138916-F67B15D2-59C3-4609-A454-53B2C7FBE12DQ35161396-6F0F593D-409D-46FF-8637-C03D63A9F10EQ35670632-CD09852E-8A8B-4046-BDD1-709995307629Q36088727-F4218B34-42A9-4D8F-96E1-2E6DA9505BA8Q36235732-9F6CC9AB-23F8-4533-8E5D-03A0E9EB34EEQ36395999-7B2AFC0E-ABCD-42C5-9BF6-D729453E485DQ36838996-28EB61A4-041E-42BF-941A-F8A12EB70136Q37022343-F46CD8D1-B7D7-4B7B-830B-3A9234D54634Q38873862-D24C51DC-6785-40DD-BE7F-EBA66CB7B685Q41279707-628542BA-B7FD-450D-806A-0A44CDB32452Q44384601-9FC380E6-ED4F-4E50-93E1-152155628D88Q47134203-98467C4B-BB56-447A-8913-B03C72353A71Q47555734-215E973D-339E-408A-8DAB-8DF689079C32Q50149863-892FA9BB-E037-45CD-929F-C055A7D83D8FQ54525844-6EC95BC6-1037-4A9A-9470-587849D48986Q55093431-C09B2A85-EC45-4744-B587-B0EC5A8DE72F
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
General overview of radioimmunotherapy of solid tumors.
@en
type
label
General overview of radioimmunotherapy of solid tumors.
@en
prefLabel
General overview of radioimmunotherapy of solid tumors.
@en
P2093
P2860
P356
P1433
P1476
General overview of radioimmunotherapy of solid tumors.
@en
P2093
André Pèlegrin
Catherine Lozza
Eric Vivès
Isabelle Navarro-Teulon
Jean-Pierre Pouget
P2860
P304
P356
10.2217/IMT.13.34
P577
2013-05-01T00:00:00Z